Previous 10 | Next 10 |
vTv Therapeutics (VTVT) inked a common stock purchase agreement for up to $47M with Chicago-based institutional investor Lincoln Park Capital Fund; optionality to sell the shares over a 3-year period.Net proceeds from the transaction to be used for general corporate purposes and to suppo...
HIGH POINT, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced it has entered into a common stock purchase agreement (“ Purchase Agreement ”) for up to $47 million with Lincoln Park Capital Fund, LLC (“ LPC ”)...
vTv Therapeutics (VTVT): Q3 GAAP EPS of -$0.03.Revenue of $0.01M.Cash position of $1.8M. Press Release For further details see: vTv Therapeutics reports Q3 results
HIGH POINT, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the third quarter ended September 30, 2020, and provided an update on the progress of its clinical programs. “Following our decision to conclude enro...
How Biotech & Psychedelic Penny Stocks Could See New Bullish Interest in 2021 If you’ve read the title and are wondering what psychedelic stocks are, you’re not alone. This niche area of the stock market has only begun to gain traction in the past few years & ...
RealNetworks (RNWK) -12% on Q3 earnings release.Aptevo Therapeutics (APVO) -12%.vTv Therapeutics (VTVT) -8% on reporting baseline characteristics for the enrolled subjects in the ongoing Elevage clinical study of azeliragon as a potential treatment for mild Alzhe...
VTv Therapeutics (VTVT) reports baseline characteristics for the enrolled subjects in the ongoing Elevage clinical study of azeliragon as a potential treatment for mild Alzheimer’s disease ((AD)) in people with type 2 diabetes.The data demonstrate that the patients enrolled in Elevage ...
HIGH POINT, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today reported baseline characteristics for the enrolled subjects in the ongoing Elevage clinical study of azeliragon as a potential treatment for mild Alzheimer’s disease (AD) in people with...
Biotech Penny Stocks To Watch Right Now With Recent & Upcoming Developments The countdown has begun and penny stocks are already part of the conversation for this week. The next few days could determine a lot not only for the U.S. but for the future of certain policymaking. As I...
Penny Stocks To Watch Before November One of the most consistently resilient industries in the stock market today is biotech. With that penny stocks have played a relatively larger role especially this year. The coronavirus has also had a hand in propelling a number of these small-c...
News, Short Squeeze, Breakout and More Instantly...
vTv Therapeutics Inc. Company Name:
VTVT Stock Symbol:
NASDAQ Market:
vTv Therapeutics Inc. Website:
HIGH POINT, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late stage biopharmaceutical company with an innovative clinical portfolio of small molecules and lead program in diabetes, today announced that the United States Food and Drug Administration (FDA) has pla...
2024-06-26 16:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Cadisegliatin is a potential first-in-class oral liver selective glucokinase activator for T1D, which has been granted Breakthrough Therapy designation by the FDA for T1D Cadisegliatin has been dosed in over ...